Skip to content

Remote Ischemic Conditioning and Platelet Dysfunction

Effect of Remote Ischemic Conditioning on Platelet Dysfunction Following Off-pump Coronary Artery Bypass Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03125681
Enrollment
58
Registered
2017-04-24
Start date
2017-05-11
Completion date
2019-02-09
Last updated
2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet Function

Keywords

remote ischemic conditioning, off-pump coronary artery bypass surgery

Brief summary

The purpose of this study is to evaluate the effects of remote ischemic conditioning on platelet function during off-pump coronary artery bypass surgery.

Detailed description

Remote ischemic conditioning (RIC) may affect platelet function. However, little is known about effect of RIC on platelet function during off-pump coronary artery bypass surgery. In this study investigators are going to perform RIC after anesthesia induction (remote ischemic pre-conditioning) and after completion of coronary anastomoses (remote ischemic post-conditioning), and compare platelet function parameters with control group.

Interventions

PROCEDURERemote ischemic conditioning

In the RIC group, RIC is performed before and after coronary anastomoses by 5 minutes limb ischemia and reperfusion with pneumatic cuff up to 200 mmHg repeated by four times.

PROCEDUREControl

In the control group, all the procedures will be same with RIC group, except for the fact that the three-way stopcock between the pneumatic cuff and the cuff inflator was opened and therefore the cuff pressure did not increase.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 20 - 80 years of adult patient undergoing elective off-pump coronary artery bypass surgery

Exclusion criteria

* Acute Myocardial Infarction * Recent (\<1 month) coronary angioplasty (percutaneous coronary intervention, PCI) * Acute cerebrovascular ischemia (\<6 months) * Preoperative LV EF \< 30%, mechanical ventricular support (IABP, VAD, ECMO) * Peripheral vascular disease * Poorly controlled diabetes mellitus * Alzheimer's disease * NSAIDs within 3 days * iv heparin within 6 h * low molecular weight heparin within 24 h * platelet inhibitor within 24 h * known thrombocytopenia * renal failure / hemodialysis * active infection * preoperative bleeding diathesis * redo-operation * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change of Multiplate ADPtest AUCBaseline, at the end of surgery, postoperative day 1Area under the aggregation curve (AUC) after platelet stimulation with adenosine diphosphate

Secondary

MeasureTime frameDescription
Change of Multiplate ASPItest AUCBaseline, at the end of surgery, postoperative day 1Area under the aggregation curve (AUC) after platelet stimulation with arachidonic acid
Change of Multiplate COLtest AUCBaseline, at the end of surgery, postoperative day 1Area under the aggregation curve (AUC) after platelet stimulation with collagen
Change of Rotational thromboelastometry EXTEM parameterBaseline, at the end of surgery, postoperative day 1Screening test for the extrinsic haemostasis system
Amount of peri-operative bleeding and transfusionAt the end of surgery, postoperative day 1,2,3Amount of peri-operative bleeding and transfusion
Rotational thromboelastometry INTEM parameterBaseline, at the end of surgery, postoperative day 1Intrinsically activated rotational thrombelastometry
Change of Rotational thromboelastometry HEPTEM parameterBaseline, at the end of surgery, postoperative day 1Represents an INTEM assay performed in the presence of heparinase
Change of Rotational thromboelastometry FIBTEM parameterBaseline, at the end of surgery, postoperative day 1Represents an EXTEM based assay for the fibrin part of the clot

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026